Persistent dyslipidemia in Chinese patients treated with lipid-lowering drugs: interim results of the dyslipidaemia international study (DYSIS) China

被引：0
|
作者：
Hu, D. Y. [1 ]
Wang, Y. J. [2 ]
Zhao, S. P. [3 ]
Mu, Y. M. [4 ]
机构：
[1] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
[2] Capital Med Univ, Tiantan Hosp, Beijing, Peoples R China
[3] Cent S Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Hunan, Peoples R China
[4] China PLA Gen Hosp, Beijing, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：797 / 797
页数：1
相关论文
共 50 条
  • [21] PREVALENCE OF LIPID ABNORMALITIES AMONG TREATED ACS PATIENTS IN GREECE: THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS) II ACS RESULTS
    Pitsavos, C.
    Alexopoulos, D.
    Goudevenos, J.
    Xixi, E.
    Gitt, A.
    Horack, M.
    Ashton, V.
    Brudi, P.
    Lautsch, D.
    Ambegaonkar, B.
    ATHEROSCLEROSIS, 2015, 241 (01) : E130 - E130
  • [22] Cost of care for patients treated with lipid-lowering drugs
    Åsa Carlsson
    Fredrik Borgström
    Jan Stålhammar
    Evo Alemao
    Don Yin
    Linus Jönsson
    PharmacoEconomics, 2004, 22 : 25 - 35
  • [23] Cost of care for patients treated with lipid-lowering drugs
    Carlsson, Å
    Borgström, F
    Stålhammar, J
    Alemao, E
    Yin, D
    Jönsson, L
    PHARMACOECONOMICS, 2004, 22 (Suppl 3) : 25 - 35
  • [24] Prevalence of lipid disorders in statin treated patients from Sweden, Norway and Denmark: Results from the Dyslipidemia International Study (DYSIS)
    Thomsen, K. Korsgaard
    Lundman, P.
    Salling, S.
    Journath, G.
    Pedersen, T.
    EUROPEAN HEART JOURNAL, 2009, 30 : 514 - 515
  • [25] PREVALENCE OF LIPID ABNORMALITIES AMONG TREATED PATIENTS WITH STABLE CHD: THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS) II SOUTH KOREA RESULTS
    Lee, S. H.
    Jeong, M. H.
    Cho, J. M.
    Kang, W. C.
    Hur, S. H.
    Jeon, D. W.
    Lee, S. H.
    Jeong, J. O.
    Cho, B. R.
    Gwon, H. C.
    Chun, K. J.
    Kim, W.
    Han, K. R.
    Seung, K. B.
    Kim, Y. H.
    Gitt, A.
    Ashton, V.
    Balaji, H. P.
    Song, W. H.
    Jang, Y. S.
    ATHEROSCLEROSIS, 2015, 241 (01) : E131 - E132
  • [26] Prevalence of lipid disorders in statin treated patients from Sweden, Norway and Denmark: results from the Dyslipidemia International Study (DYSIS)
    Thomsen, Kristian Korsgaard
    Salling, Soren
    Lundman, Pia
    Journath, Gunilla
    Pedersen, Terje
    CARDIOLOGY, 2009, 113 : 116 - 116
  • [27] Body mass index impacts the choice of lipid-lowering treatment with no correlation to blood cholesterol - Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS)
    Ferrieres, Jean
    Lautsch, Dominik
    Gitt, Anselm K.
    De Ferrari, Gaetano
    Toplak, Hermann
    Elisaf, Moses
    Drexel, Heinz
    Horack, Martin
    Baxter, Carl
    Ambegaonkar, Baishali
    Brudi, Philippe
    Toth, Peter P.
    DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2670 - 2674
  • [28] Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
    Graham, DJ
    Staffa, JA
    Shatin, D
    Andrade, SE
    Schech, SD
    La Grenade, L
    Gurwitz, JH
    Chan, KA
    Goodman, MJ
    Platt, R
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (21): : 2585 - 2590
  • [29] Incidence of severe myositis in patients treated with lipid-lowering drugs
    Kim, Ju Young
    Park, Byung Joo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S250 - S250
  • [30] Prevalence of dyslipidaemia in patients treated with lipid-modifying drugs in the Netherlands Part of the Dyslipidaemia International Study
    Strang, A. C.
    Kaasjager, H. A. H.
    Basart, D. C. G.
    Stroes, E. S. G.
    NETHERLANDS JOURNAL OF MEDICINE, 2010, 68 (04): : 168 - 174
12345